Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder

Sertraline is one among several selective serotonin reuptake inhibitors (SSRIs) that exhibited improvement of language development in Autism Spectrum Disorder (ASD); however, the molecular mechanism has not been elucidated. A double blind, randomized, 6-month, placebo-controlled, clinical trial of l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Genet
Autores principales: Alolaby, Reem Rafik, Jiraanont, Poonnada, Durbin-Johnson, Blythe, Jasoliya, Mittal, Tang, Hiu-Tung, Hagerman, Randi, Tassone, Flora
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Genetics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7174723/
https://ncbi.nlm.nih.gov/pubmed/32346385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2020.00308
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares